Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 26


Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information.

Zhao X, Perez-Aguilar JM, Matsunaga F, Lerner M, Xi J, Selling B, Johnson AT Jr, Saven JG, Liu R.

Anesthesiology. 2014 Oct;121(4):866-75. doi: 10.1097/ALN.0000000000000308.


Small molecule proprotein convertase inhibitors for inhibition of embryo implantation.

Ho H, Singh H, Heng S, Nero TL, Paule S, Parker MW, Johnson AT, Jiao GS, Nie G.

PLoS One. 2013 Dec 4;8(12):e81380. doi: 10.1371/journal.pone.0081380. eCollection 2013.


Validity of a new respiratory resistance measurement device to detect glottal area change.

Gallena SJ, Tian W, Johnson AT, Vossoughi J, Sarles SA, Solomon NP.

J Voice. 2013 May;27(3):299-304. doi: 10.1016/j.jvoice.2013.01.006. Epub 2013 Mar 15.


Detecting Lyme disease using antibody-functionalized single-walled carbon nanotube transistors.

Lerner MB, Dailey J, Goldsmith BR, Brisson D, Johnson AT.

Biosens Bioelectron. 2013 Jul 15;45:163-7. doi: 10.1016/j.bios.2013.01.035. Epub 2013 Feb 4.


Teaching the principle of biological optimization.

Johnson AT.

J Biol Eng. 2013 Feb 20;7(1):6. doi: 10.1186/1754-1611-7-6.


Hybrids of a genetically engineered antibody and a carbon nanotube transistor for detection of prostate cancer biomarkers.

Lerner MB, D'Souza J, Pazina T, Dailey J, Goldsmith BR, Robinson MK, Johnson AT.

ACS Nano. 2012 Jun 26;6(6):5143-9. doi: 10.1021/nn300819s. Epub 2012 May 17.


Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.

Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ, Schmechel SC.

Diagn Pathol. 2012 Jun 20;7:42. doi: 10.1186/1746-1596-7-42.


Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.

Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2242-6. doi: 10.1016/j.bmcl.2012.01.095. Epub 2012 Feb 1.


Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Vivoli M, Caulfield TR, Martínez-Mayorga K, Johnson AT, Jiao GS, Lindberg I.

Mol Pharmacol. 2012 Mar;81(3):440-54. doi: 10.1124/mol.111.077040. Epub 2011 Dec 14.


In situ electronic characterization of graphene nanoconstrictions fabricated in a transmission electron microscope.

Lu Y, Merchant CA, Drndić M, Johnson AT.

Nano Lett. 2011 Dec 14;11(12):5184-8. doi: 10.1021/nl2023756. Epub 2011 Nov 2.


Using CO(2) to determine inhaled contaminant volumes and blower effectiveness in several types of respirators.

Johnson AT, Koh FC, Scott WH Jr, Rehak TE.

J Environ Public Health. 2011;2011:402148. doi: 10.1155/2011/402148. Epub 2011 Jul 18.


Biomimetic chemical sensors using nanoelectronic readout of olfactory receptor proteins.

Goldsmith BR, Mitala JJ, Josue J, Castro A, Lerner MB, Bayburt TH, Khamis SM, Jones RA, Brand JG, Sligar SG, Luetje CW, Gelperin A, Rhodes PA, Discher BM, Johnson AT.

ACS Nano. 2011 Jul 26;5(7):5408-16. doi: 10.1021/nn200489j. Epub 2011 Jul 6.


Inward leakage in tight-fitting PAPRs.

Koh FC, Johnson AT, Rehak TE.

J Environ Public Health. 2011;2011:473143. doi: 10.1155/2011/473143. Epub 2011 May 12.


Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA.

Antivir Chem Chemother. 2011 May 12;21(5):209-17. doi: 10.3851/IMP1767.


Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60/70 loop flexibility.

Thompson AA, Jiao GS, Kim S, Thai A, Cregar-Hernandez L, Margosiak SA, Johnson AT, Han GW, O'Malley S, Stevens RC.

Biochemistry. 2011 May 17;50(19):4019-28. doi: 10.1021/bi2001483. Epub 2011 Apr 21.


Antidotes to anthrax lethal factor intoxication. Part 2: structural modifications leading to improved in vivo efficacy.

Kim S, Jiao GS, Moayeri M, Crown D, Cregar-Hernandez L, McKasson L, Margosiak SA, Leppla SH, Johnson AT.

Bioorg Med Chem Lett. 2011 Apr 1;21(7):2030-3. doi: 10.1016/j.bmcl.2011.02.010. Epub 2011 Feb 18.


GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N.

Carcinogenesis. 2011 Feb;32(2):182-9. doi: 10.1093/carcin/bgq223. Epub 2010 Oct 29.


Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy.

Jiao GS, Kim S, Moayeri M, Cregar-Hernandez L, McKasson L, Margosiak SA, Leppla SH, Johnson AT.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6850-3. doi: 10.1016/j.bmcl.2010.08.058. Epub 2010 Aug 15.


Testing limits to airflow perturbation device (APD) measurements.

Lopresti ER, Johnson AT, Koh FC, Scott WH, Jamshidi S, Silverman NK.

Biomed Eng Online. 2008 Oct 31;7:28. doi: 10.1186/1475-925X-7-28.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk